• Health & Medicine

England off track to meet government's 2030 smoke-free target

England will fail to be smoke-free by 2030 if current smoking trends continue, according to a report released today from Cancer Research UK. England will fail to be smoke-free by 2030 if current smoking trends continue, according to a report released today from Cancer Research UK.

25 February 2020

• Science & Technology
• Health & Medicine

News digest – statins, cellular communication, new fertility technique and vaping

In the news this week: statins may reduce risk of ovarian cancer and scientists reveal how cancer cells communicate. In the news this week: statins may reduce risk of ovarian cancer and scientists reveal how cancer cells communicate.

22 February 2020

• Health & Medicine

Research suggests statins could lower ovarian cancer risk

A genetic study has found evidence to suggest that women who take statins in the long term could be less likely to develop ovarian cancer. A genetic study has found evidence to suggest that women who take statins in the long term could be less likely to develop ovarian cancer.

18 February 2020

• Health & Medicine

Kidney cancer drug gets initial ‘no’ for the NHS in England

A new kidney cancer drug combination of pembrolizumab with axitinib gets an initial no for the NHS in England A new kidney cancer drug combination of pembrolizumab with axitinib gets an initial no for the NHS in England

17 February 2020

• Science & Technology
• Health & Medicine

News digest – robot surgery, cancer information, drug decisions and prebiotics

In the news this week: A survey has revealed a third of cancer patients fail to receive vital information and robots are used in breast cancer surgery. In the news this week: A survey has revealed a third of cancer patients fail to receive vital information and robots are used in breast cancer surgery.

15 February 2020

• Health & Medicine

Two skin cancer treatments get the green light for NHS Scotland

An immunotherapy and a targeted cancer drug were among the latest batch of NHS approvals from the Scottish Medicines Consortium (SMC).  An immunotherapy and a targeted cancer drug were among the latest batch of NHS approvals from the Scottish Medicines Consortium (SMC). 

12 February 2020

• Science & Technology
• Health & Medicine

News digest – cataloguing cancer genomes, gene-edited immune cells and NHS finances

In the news this week: scientists have completed the most comprehensive study of cancer genetics to date. In the news this week: scientists have completed the most comprehensive study of cancer genetics to date.

8 February 2020

• Health & Medicine

Targeted lung cancer treatment gets initial ‘no’ for NHS in England

Adults in England with advanced lung cancer will not have access to a new targeted cancer drug, lorlatinib (Lorviqua).  Adults in England with advanced lung cancer will not have access to a new targeted cancer drug, lorlatinib (Lorviqua). 

4 February 2020

• Science & Technology
• Health & Medicine

News digest – ex-smokers’ lungs, NHS staff shortages, Brexit and breast cancer genes

In the news this week: protective cells lining the lungs of ex-smokers could explain why quitting smoking reduces lung cancer risk. In the news this week: protective cells lining the lungs of ex-smokers could explain why quitting smoking reduces lung cancer risk.

1 February 2020

• Health & Medicine

What happens after Brexit and what could it mean for cancer?

At 11pm on Friday 31st January, the UK will leave the European Union. And the big question is – what happens next? At 11pm on Friday 31st January, the UK will leave the European Union. And the big question is – what happens next?

31 January 2020

• Health & Medicine

Never too late to quit: protective cells could cut risk of lung cancer for ex-smokers

Protective cells in the lungs of ex-smokers could explain why quitting smoking reduces the risk of developing lung cancer. Protective cells in the lungs of ex-smokers could explain why quitting smoking reduces the risk of developing lung cancer.

29 January 2020

• Health & Medicine

NHS staff shortages mean patients miss out on early bowel cancer diagnosis

Around 1,100 people in England could miss out on the chance of an early stage bowel cancer diagnosis through screening each year because of NHS staff shortages. Around 1,100 people in England could miss out on the chance of an early stage bowel cancer diagnosis through screening each year because of NHS staff shortages.

28 January 2020